NCT02679248View on ClinicalTrials.gov

A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults

PHASE2TerminatedINTERVENTIONAL

Enrollment

67

Participants

Timeline

Start Date

February 3, 2016

Primary Completion Date

February 3, 2017

Study Completion Date

March 31, 2017

Conditions

Pre-hypertension

Interventions

DIETARY_SUPPLEMENT

Neo40 Daily®

DIETARY_SUPPLEMENT

Placebo

Trial Locations (2)

N6A 5R8

KGK Synergize Inc., London

M9W 4L6

Manna Research - Toronto, Toronto

Sponsors

Lead Sponsor

KGK Science Inc.

Collaborators (1)

Neogenis Laboratories

All Listed Sponsors

collaborator

Neogenis Laboratories

OTHER

lead

KGK Science Inc.

INDUSTRY

NCT02679248 - A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults | Biotech Hunter | Biotech Hunter